PIIND2026-06-24PIIND2026-06-242026-06-24PIIND2026-06-24in-capmkt:FinancialYear1MemberPIIND2026-06-24in-capmkt:FinancialYear2MemberPIIND2026-06-24in-capmkt:FinancialYear3MemberPIIND2026-06-242026-06-24in-capmkt:FinancialYear1MemberPIIND2026-06-242026-06-24in-capmkt:FinancialYear2MemberPIIND2026-06-242026-06-24in-capmkt:FinancialYear3Memberiso4217:INRxbrli:pure523642PI INDUSTRIES LIMITEDPIINDNOTLISTEDINE603J01030NewAcquisition (including agreement to acquire)true2026-06-2318:30:002026-06-24The transaction is a Related Party Transaction (RPT) with a wholly-owned subsidiary, requiring only Audit Committee approval, which has been duly obtained. The Board and Shareholder's approvals are exempt for this transaction. However, the utility system mandates entry of approval dates for both Board and Shareholders. Accordingly, for validation purposes, the RPT field has been marked as "No" in the utility.PI Industries LimitedListed Entity (self)PI Health Sciences Limited ('PIHS')580500000-13424000002720900000falsefalsetruePharma - Contract Research Development and Manufacturing Organisation (CRDMO)The conversion of Optionally Fully Convertible Debentures (OFCDs) into equity shares is being undertaken in accordance with the terms of issuance. The conversion shall strengthen the consolidated balance sheet of the Company and its subsidiaries.NAfalseAt the time of conversion of OFCDs into equity sharesOthersThe transaction does not involve cash consideration/share swap by PI Industries and does not result in any change in its ownership or control of PIHS.100000000001PIHS is a wholly owned subsidiary of the Company, engaged in CRDMO business.2021-09-032025-20265805000002024-20253556000002023-2024277000000India